Merit Medical Systems, Inc. (NASDAQ:MMSI) – Stock analysts at SunTrust Banks raised their Q2 2018 earnings per share (EPS) estimates for Merit Medical Systems in a report released on Tuesday. SunTrust Banks analyst B. Nudell now expects that the medical instruments supplier will earn $0.43 per share for the quarter, up from their previous estimate of $0.37. SunTrust Banks has a “Buy” rating and a $55.00 price objective on the stock. SunTrust Banks also issued estimates for Merit Medical Systems’ Q3 2018 earnings at $0.42 EPS, Q4 2018 earnings at $0.45 EPS, FY2018 earnings at $1.64 EPS and FY2019 earnings at $1.86 EPS.
Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Wednesday, February 28th. The medical instruments supplier reported $0.33 EPS for the quarter, topping the Zacks’ consensus estimate of $0.32 by $0.01. The company had revenue of $190.90 million for the quarter, compared to analyst estimates of $187.62 million. Merit Medical Systems had a return on equity of 9.65% and a net margin of 3.78%. Merit Medical Systems’s revenue was up 21.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.31 earnings per share.
Shares of Merit Medical Systems (MMSI) opened at $45.95 on Thursday. The company has a market capitalization of $2,322.33, a PE ratio of 35.81, a PEG ratio of 2.17 and a beta of 1.28. The company has a current ratio of 2.73, a quick ratio of 1.39 and a debt-to-equity ratio of 0.38. Merit Medical Systems has a 1 year low of $27.65 and a 1 year high of $49.50.
A number of hedge funds have recently bought and sold shares of the business. Eagle Asset Management Inc. grew its stake in Merit Medical Systems by 209.5% in the fourth quarter. Eagle Asset Management Inc. now owns 1,874,146 shares of the medical instruments supplier’s stock valued at $81,018,000 after purchasing an additional 1,268,635 shares in the last quarter. Carillon Tower Advisers Inc. bought a new position in Merit Medical Systems in the fourth quarter valued at approximately $13,788,000. Perceptive Advisors LLC grew its stake in Merit Medical Systems by 774.0% in the fourth quarter. Perceptive Advisors LLC now owns 874,013 shares of the medical instruments supplier’s stock valued at $37,757,000 after purchasing an additional 774,013 shares in the last quarter. Rockefeller Financial Services Inc. grew its stake in Merit Medical Systems by 4.6% in the fourth quarter. Rockefeller Financial Services Inc. now owns 781,227 shares of the medical instruments supplier’s stock valued at $33,749,000 after purchasing an additional 34,175 shares in the last quarter. Finally, Teachers Advisors LLC grew its stake in Merit Medical Systems by 0.6% in the fourth quarter. Teachers Advisors LLC now owns 638,426 shares of the medical instruments supplier’s stock valued at $27,580,000 after purchasing an additional 4,038 shares in the last quarter. Hedge funds and other institutional investors own 94.17% of the company’s stock.
In related news, Director Franklin J. Miller sold 10,000 shares of the stock in a transaction dated Friday, December 29th. The stock was sold at an average price of $43.93, for a total transaction of $439,300.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kent W. Stanger sold 9,082 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $44.90, for a total value of $407,781.80. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 29,082 shares of company stock valued at $1,286,382. 5.00% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION WARNING: “SunTrust Banks Brokers Boost Earnings Estimates for Merit Medical Systems, Inc. (MMSI)” was published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at https://sportsperspectives.com/2018/03/10/suntrust-banks-brokers-boost-earnings-estimates-for-merit-medical-systems-inc-mmsi.html.
About Merit Medical Systems
Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.